NCI | Technology Transfer

PEPTIDE HYDROGELS AND USE THEREOF

Read more about PEPTIDE HYDROGELS AND USE THEREOF

US Patent 11,661,439
Filed on 2020-06-16

M971 CHIMERIC ANTIGEN RECEPTORS

Read more about M971 CHIMERIC ANTIGEN RECEPTORS

US Patent 11,807,682
Filed on 2020-05-08

T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3

Read more about T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3

Israel
274003
Filed on 2020-04-16

USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT METASTASIS

Read more about USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT METASTASIS

US Patent 11,351,185
Filed on 2020-03-11

THYMIC STROMAL LYMPHOPOIETIN RECEPTOR-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME

Read more about THYMIC STROMAL LYMPHOPOIETIN RECEPTOR-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME

US Patent 11,834,509
Filed on 2020-04-28

VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS

Read more about VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS

US Patent 11,110,181
Filed on 2020-01-31

TREATING OR PREVENTING ADVERSE LIVER CONDITIONS

Read more about TREATING OR PREVENTING ADVERSE LIVER CONDITIONS

US Patent 11,771,737
Filed on 2020-04-17

ANTI-MUTATED KRAS T CELL RECEPTORS

Read more about ANTI-MUTATED KRAS T CELL RECEPTORS

Australia
2020203465
Filed on 2020-05-26

ANTI-CD276 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS

Read more about ANTI-CD276 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS

US Patent 11,512,138
Filed on 2020-03-18

METHODS FOR ISOLATING T CELL RECEPTORS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS

Read more about METHODS FOR ISOLATING T CELL RECEPTORS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS

Japan
2020-066108
Filed on 2020-04-01

Subscribe to NCI